IFNG and breast carcinoma: These data suggest that loss of pY239/240ShcA signalling downstream of tyrosine kinases inhibits immunosuppressive signals in breast cancer cells, which sensitizes them to stromally derived, IFNγ-inducible immune surveillance pathways in vivo.